London, July 4 (TIWN) Patients with a wide range of cancers, taking aspirin as part of their treatment, could help to reduce their risk of death by 20 per cent, a major review of existing research has suggested.

As part of the study, the team reviewed 118 earlier published studies, which included 250,000 patients with 18 different cancers.  They also considered the risks of aspirin-taking and wrote to the authors of the papers, asking about any stomach or other bleeding episodes.   Advertisement A small number of patients had experienced a bleed, but there was no evidence of any excess deaths attributable to bleeding in the patients on aspirin, the review found.